SwePub
Sök i LIBRIS databas

  Utökad sökning

WFRF:(Liu You Bin)
 

Sökning: WFRF:(Liu You Bin) > Prognostic Heteroge...

  • Fan, Chuan-WenInstitute of Digestive Surgery, State Key Laboratory of Biotherapy and Cancer Center, West China Hospital, Sichuan University, and Collaborative Innovation Center for Biotherapy, Chengdu, China; Department of Oncology, Clinical and Experimental Medicine, Linköping University, Linköping, Sweden (författare)

Prognostic Heterogeneity of MRE11 Based on the Location of Primary Colorectal Cancer Is Caused by Activation of Different Immune Signals

  • Artikel/kapitelEngelska2020

Förlag, utgivningsår, omfång ...

  • 2020-01-17
  • Frontiers Media S.A.2020
  • printrdacarrier

Nummerbeteckningar

  • LIBRIS-ID:oai:DiVA.org:oru-79887
  • https://urn.kb.se/resolve?urn=urn:nbn:se:oru:diva-79887URI
  • https://doi.org/10.3389/fonc.2019.01465DOI
  • https://urn.kb.se/resolve?urn=urn:nbn:se:liu:diva-163666URI

Kompletterande språkuppgifter

  • Språk:engelska
  • Sammanfattning på:engelska

Ingår i deldatabas

Klassifikation

  • Ämneskategori:ref swepub-contenttype
  • Ämneskategori:art swepub-publicationtype

Anmärkningar

  • Funding Agencies:Oncology Clinics in Linköping  National Natural Science Foundation of China 81402446Research Foundation of Health and Family Planning Commission of Sichuan Province, China  150136
  • Funding Agencies|Swedish Cancer Foundation; Swedish Research CouncilSwedish Research Council; Oncology Clinics in Linkoping; National Science Foundation of ChinaNational Natural Science Foundation of China [81402446]; Research Foundation of Health and Family Planning Commission of Sichuan Province, China [150136]
  • Background: MRE11 plays an important role in DNA damage response for the maintenance of genome stability, and is becoming a prognostic marker for cancers, including colorectal cancer (CRC). However, the correlations of MRE11 to prognosis and tumor-infiltrating inflammatory cells (TIICs) in different locations of CRC remains unclear.Methods: Among Swedish and TCGA-COREAD patients, we investigated the association of MRE11 expression, tumor-infiltrating inflammatory cells (TIICs) and microsatellite status with survival in right-sided colon cancer (RSCC) and left-sided colon and rectal cancer (LSCRC). The signaling of MRE11-related was further analyzed using weighted gene co-expression network analysis and ClueGO. Results: High MRE11 expression alone or combination of high MRE11 expression with high TIICs was related to favorable prognosis in LSCRC. Moreover, high MRE11 expression was associated with favorable prognosis in LSCRC with microsatellite stability. The relationships above were adjusted for tumor stage, differentiation, and/or TIICs. However, no such evidence was observed in RSCC. Several signaling pathways involving MRE11 were found to be associated with cell cycle and DNA repair in RSCC and LSCRC, whereas, the activation of the immune response and necrotic cell death were specifically correlated with LSCRC.Conclusions: High MRE11 expression is an independent prognostic marker in LSCRC and enhanced prognostic potency of combining high MRE11 with high TIICs in LSCRC, mainly due to differential immune signaling activated by MRE11 in RSCC and LSCRC, respectively.

Ämnesord och genrebeteckningar

Biuppslag (personer, institutioner, konferenser, titlar ...)

  • Kopsida, MariaLinköpings universitet,Avdelningen för kirurgi, ortopedi och onkologi,Medicinska fakulteten,Region Östergötland, Onkologiska kliniken US(Swepub:liu)marko66 (författare)
  • Liu, You-BinInstitute of Digestive Surgery, State Key Laboratory of Biotherapy and Cancer Center, West China Hospital, Sichuan University, and Collaborative Innovation Center for Biotherapy, Chengdu, China; Department of Oncology, Clinical and Experimental Medicine, Linköping University, Linköping, Sweden (författare)
  • Zhang, Hong,1957-Örebro universitet,Institutionen för medicinska vetenskaper,Orebro Univ, Sweden,Sichuan Univ, Peoples R China; Collaborat Innovat Ctr Biotherapy, Peoples R China(Swepub:oru)hzg (författare)
  • Gao, Jing-FangDepartment of Oncology, Clinical and Experimental Medicine, Linköping University, Linköping, Sweden (författare)
  • Arbman, GunnarLinköpings universitet,Institutionen för klinisk och experimentell medicin,Medicinska fakulteten,Region Östergötland, Onkologiska kliniken US(Swepub:liu)gunar63 (författare)
  • Cao, Si-Yu-WeiLinköpings universitet,Avdelningen för kirurgi, ortopedi och onkologi,Medicinska fakulteten,Region Östergötland, Onkologiska kliniken US(Swepub:liu)n/a (författare)
  • Li, YuanInstitute of Digestive Surgery, State Key Laboratory of Biotherapy and Cancer Center, West China Hospital, Sichuan University, and Collaborative Innovation Center for Biotherapy, Chengdu, China,Sichuan Univ, Peoples R China; Collaborat Innovat Ctr Biotherapy, Peoples R China (författare)
  • Zhou, Zong-GuangInstitute of Digestive Surgery, State Key Laboratory of Biotherapy and Cancer Center, West China Hospital, Sichuan University, and Collaborative Innovation Center for Biotherapy, Chengdu, China (författare)
  • Sun, Xiao-FengLinköpings universitet,Avdelningen för kirurgi, ortopedi och onkologi,Medicinska fakulteten,Region Östergötland, Onkologiska kliniken US(Swepub:liu)xiasu45 (författare)
  • Fan, ChuanwenLinköpings universitet,Avdelningen för kirurgi, ortopedi och onkologi,Medicinska fakulteten,Region Östergötland, Onkologiska kliniken US,Sichuan Univ, Peoples R China; Collaborat Innovat Ctr Biotherapy, Peoples R China(Swepub:liu)chufa37 (författare)
  • Liu, YoubinLinköpings universitet,Avdelningen för kirurgi, ortopedi och onkologi,Medicinska fakulteten,Region Östergötland, Onkologiska kliniken US,Sichuan Univ, Peoples R China; Collaborat Innovat Ctr Biotherapy, Peoples R China(Swepub:liu)youli96 (författare)
  • Gao, JingfangLinköpings universitet,Avdelningen för kirurgi, ortopedi och onkologi,Medicinska fakulteten,Region Östergötland, Onkologiska kliniken US(Swepub:liu)jinga59 (författare)
  • Institute of Digestive Surgery, State Key Laboratory of Biotherapy and Cancer Center, West China Hospital, Sichuan University, and Collaborative Innovation Center for Biotherapy, Chengdu, China; Department of Oncology, Clinical and Experimental Medicine, Linköping University, Linköping, SwedenAvdelningen för kirurgi, ortopedi och onkologi (creator_code:org_t)

Sammanhörande titlar

  • Ingår i:Frontiers in Oncology: Frontiers Media S.A.92234-943X

Internetlänk

Hitta via bibliotek

Till lärosätets databas

Kungliga biblioteket hanterar dina personuppgifter i enlighet med EU:s dataskyddsförordning (2018), GDPR. Läs mer om hur det funkar här.
Så här hanterar KB dina uppgifter vid användning av denna tjänst.

 
pil uppåt Stäng

Kopiera och spara länken för att återkomma till aktuell vy